Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ellen De Meester is active.

Publication


Featured researches published by Ellen De Meester.


Nucleic Acids Research | 2015

PROTEOFORMER: deep proteome coverage through ribosome profiling and MS integration

Jeroen Crappé; Elvis Ndah; Alexander Koch; Sandra Steyaert; Daria Gawron; Sarah De Keulenaer; Ellen De Meester; Tim De Meyer; Wim Van Criekinge; Petra Van Damme; Gerben Menschaert

An increasing amount of studies integrate mRNA sequencing data into MS-based proteomics to complement the translation product search space. However, several factors, including extensive regulation of mRNA translation and the need for three- or six-frame-translation, impede the use of mRNA-seq data for the construction of a protein sequence search database. With that in mind, we developed the PROTEOFORMER tool that automatically processes data of the recently developed ribosome profiling method (sequencing of ribosome-protected mRNA fragments), resulting in genome-wide visualization of ribosome occupancy. Our tool also includes a translation initiation site calling algorithm allowing the delineation of the open reading frames (ORFs) of all translation products. A complete protein synthesis-based sequence database can thus be compiled for mass spectrometry-based identification. This approach increases the overall protein identification rates with 3% and 11% (improved and new identifications) for human and mouse, respectively, and enables proteome-wide detection of 5′-extended proteoforms, upstream ORF translation and near-cognate translation start sites. The PROTEOFORMER tool is available as a stand-alone pipeline and has been implemented in the galaxy framework for ease of use.


Genetics in Medicine | 2012

Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis

Frauke Coppieters; Bram De Wilde; Steve Lefever; Ellen De Meester; Nina De Rocker; Caroline Van Cauwenbergh; Filip Pattyn; Françoise Meire; Bart P. Leroy; Jan Hellemans; Jo Vandesompele; Elfride De Baere

Purpose:Leber congenital amaurosis (LCA) is a rare congenital retinal dystrophy associated with 16 genes. Recent breakthroughs in LCA gene therapy offer the first prospect of treating inherited blindness, which requires an unequivocal and early molecular diagnosis. While present genetic tests do not address this due to a tremendous genetic heterogeneity, massively parallel sequencing (MPS) strategies might bring a solution. Here, we developed a comprehensive molecular test for LCA based on targeted MPS of all exons of 16 known LCA genes.Methods:We designed a unique and flexible workflow for targeted resequencing of all 236 exons from 16 LCA genes based on quantitative PCR (qPCR) amplicon ligation, shearing, and parallel sequencing of multiple patients on a single lane of a short-read sequencer. Twenty-two prescreened LCA patients were included, five of whom had a known molecular cause.Results:Validation of 107 variations was performed as proof of concept. In addition, the causal genetic defect and a single heterozygous mutation were identified in 3 and 5, respectively, of 17 patients without previously identified mutations.Conclusion:We propose a novel targeted MPS-based approach that is suitable for accurate, fast, and cost-effective early molecular testing in LCA, and easily applicable in other genetic disorders.Genet Med 2012:14(6):576–585


Proteomics | 2014

A proteogenomics approach integrating proteomics and ribosome profiling increases the efficiency of protein identification and enables the discovery of alternative translation start sites

Alexander Koch; Daria Gawron; Sandra Steyaert; Elvis Ndah; Jeroen Crappé; Sarah De Keulenaer; Ellen De Meester; Ming Ma; Ben Shen; Kris Gevaert; Wim Van Criekinge; Petra Van Damme; Gerben Menschaert

Next‐generation transcriptome sequencing is increasingly integrated with MS to enhance MS‐based protein and peptide identification. Recently, a breakthrough in transcriptome analysis was achieved with the development of ribosome profiling (ribo‐seq). This technology is based on the deep sequencing of ribosome‐protected mRNA fragments, thereby enabling the direct observation of in vivo protein synthesis at the transcript level. In order to explore the impact of a ribo‐seq‐derived protein sequence search space on MS/MS spectrum identification, we performed a comprehensive proteome study on a human cancer cell line, using both shotgun and N‐terminal proteomics, next to ribosome profiling, which was used to delineate (alternative) translational reading frames. By including protein‐level evidence of sample‐specific genetic variation and alternative translation, this strategy improved the identification score of 69 proteins and identified 22 new proteins in the shotgun experiment. Furthermore, we discovered 18 new alternative translation start sites in the N‐terminal proteomics data and observed a correlation between the quantitative measures of ribo‐seq and shotgun proteomics with a Pearson correlation coefficient ranging from 0.483 to 0.664. Overall, this study demonstrated the benefits of ribosome profiling for MS‐based protein and peptide identification and we believe this approach could develop into a common practice for next‐generation proteomics.


Scientific Reports | 2015

Development and performance of a targeted whole exome sequencing enrichment kit for the dog (Canis Familiaris Build 3.1)

Bart Broeckx; Frank Coopman; Geert Verhoeven; Valérie Bavegems; Sarah De Keulenaer; Ellen De Meester; Filip Van Niewerburgh; Dieter Deforce

Whole exome sequencing is a technique that aims to selectively sequence all exons of protein-coding genes. A canine whole exome sequencing enrichment kit was designed based on the latest canine reference genome (build 3.1.72). Its performance was tested by sequencing 2 exome captures, each consisting of 4 pre-capture pooled, barcoded Illumina libraries on an Illumina HiSeq 2500. At an average sequencing depth of 102x, 83 to 86% of the target regions were completely sequenced with a minimum coverage of five and 90% of the reads mapped on the target regions. Additionally, it is shown that the reproducibility within and between captures is high and that pooling four samples per capture is a valid option. Overall, we have demonstrated the strong performance of this WES enrichment kit and are confident it will be a valuable tool in future disease association studies.


Scientific Reports | 2015

Improved canine exome designs, featuring ncRNAs and increased coverage of protein coding genes

Bart Broeckx; Christophe Hitte; Frank Coopman; Geert Verhoeven; Sarah De Keulenaer; Ellen De Meester; Thomas Derrien; Jessica Alföldi; Kerstin Lindblad-Toh; Tim Bosmans; Ingrid Gielen; Henri van Bree; Bernadette Van Ryssen; Jimmy Saunders; Filip Van Nieuwerburgh; Dieter Deforce

By limiting sequencing to those sequences transcribed as mRNA, whole exome sequencing is a cost-efficient technique often used in disease-association studies. We developed two target enrichment designs based on the recently released annotation of the canine genome: the exome-plus design and the exome-CDS design. The exome-plus design combines the exons of the CanFam 3.1 Ensembl annotation, more recently discovered protein-coding exons and a variety of non-coding RNA regions (microRNAs, long non-coding RNAs and antisense transcripts), leading to a total size of ≈152 Mb. The exome-CDS was designed as a subset of the exome-plus by omitting all 3’ and 5’ untranslated regions. This reduced the size of the exome-CDS to ≈71 Mb. To test the capturing performance, four exome-plus captures were sequenced on a NextSeq 500 with each capture containing four pre-capture pooled, barcoded samples. At an average sequencing depth of 68.3x, 80% of the regions and well over 90% of the targeted base pairs were completely covered at least 5 times with high reproducibility. Based on the performance of the exome-plus, we estimated the performance of the exome-CDS. Overall, these designs provide flexible solutions for a variety of research questions and are likely to be reliable tools in disease studies.


Scientific Reports | 2016

A genome-wide search for epigenetically regulated genes in zebra finch using MethylCap-seq and RNA-seq

Sandra Steyaert; Jolien Diddens; Jeroen Galle; Ellen De Meester; Sarah De Keulenaer; Antje Bakker; Nina Sohnius-Wilhelmi; Carolina Frankl-Vilches; Anne-Marie Van Der Linden; Wim Van Criekinge; Wim Vanden Berghe; Tim De Meyer

Learning and memory formation are known to require dynamic CpG (de)methylation and gene expression changes. Here, we aimed at establishing a genome-wide DNA methylation map of the zebra finch genome, a model organism in neuroscience, as well as identifying putatively epigenetically regulated genes. RNA- and MethylCap-seq experiments were performed on two zebra finch cell lines in presence or absence of 5-aza-2′-deoxycytidine induced demethylation. First, the MethylCap-seq methodology was validated in zebra finch by comparison with RRBS-generated data. To assess the influence of (variable) methylation on gene expression, RNA-seq experiments were performed as well. Comparison of RNA-seq and MethylCap-seq results showed that at least 357 of the 3,457 AZA-upregulated genes are putatively regulated by methylation in the promoter region, for which a pathway analysis showed remarkable enrichment for neurological networks. A subset of genes was validated using Exon Arrays, quantitative RT-PCR and CpG pyrosequencing on bisulfite-treated samples. To our knowledge, this study provides the first genome-wide DNA methylation map of the zebra finch genome as well as a comprehensive set of genes of which transcription is under putative methylation control.


International Journal of Molecular Sciences | 2018

Photothermally Triggered Endosomal Escape and Its Influence on Transfection Efficiency of Gold-Functionalized JetPEI/pDNA Nanoparticles

Lotte Vermeulen; Juan Fraire; Laurens Raes; Ellen De Meester; Sarah De Keulenaer; Filip Van Nieuwerburgh; Stefaan C. De Smedt; Katrien Remaut; Kevin Braeckmans

Plasmonic nanoparticles for drug delivery have attracted increasing interest over the last few years. Their localized surface plasmon resonance causes photothermal effects on laser irradiation, which allows for delivering drugs in a spatio-temporally controlled manner. Here, we explore the use of gold nanoparticles (AuNP) as carriers for pDNA in combination with pulsed laser irradiation to induce endosomal escape, which is currently considered to be one of the major bottlenecks in macromolecular drug delivery on the intracellular level. In particular, we evaluate nanocomplexes composed of JetPEI (polyethylenimine)pDNA and 10 nm AuNP, which do not exhibit endosomal escape by themselves. After incubating HeLa cells with these complexes, we evaluated endosomal escape and transfection efficiency using low- and high-energy laser pulses. At low laser energy heat is produced by the nanocomplexes, while, at higher laser energy, explosive vapour nanobubbles (VNB) are formed. We investigated the ability of heat transfer and VNB formation to induce endosomal escape and we examine the integrity of pDNA cargo after inducing both photothermal effects. We conclude that JetPEI/pDNA/AuNP complexes are unable to induce meaningful transfection efficiencies because laser treatment causes either dysfunctionality of the cargo when VNB are formed or forms too small pores in the endosomal membrane to allow pDNA to escape in case of heating. We conclude that laser-induced VNB is the most suitable to induce effective pDNA endosomal escape, but a different nanocomplex structure will be required to keep the pDNA intact.


Scientific Reports | 2016

Erratum: Corrigendum: A genome-wide search for epigenetically regulated genes in zebra finch using MethylCap-seq and RNA-seq

Sandra Steyaert; Jolien Diddens; Jeroen Galle; Ellen De Meester; Sarah De Keulenaer; Antje Bakker; Nina Sohnius-Wilhelmi; Carolina Frankl-Vilches; Annemie Van der Linden; Wim Van Criekinge; Wim Vanden Berghe; Tim Meyer

Scientific Reports 6: Article number: 20957; 10.1038/srep20957 published online: February112016; updated: March172016 The original version of this Article contained an error in the title of the paper, where the word “epigenetically” was incorrectly given as “eigenetically”. This has now been corrected in the PDF and HTML versions of the Article.


Scientific Reports | 2016

Corrigendum: A genome-wide search for epigenetically regulated genes in zebra finch using MethylCap-seq and RNA-seq

Sandra Steyaert; Jolien Diddens; Jeroen Galle; Ellen De Meester; Sarah De Keulenaer; Antje Bakker; Nina Sohnius-Wilhelmi; Carolina Frankl-Vilches; Annemie Van der Linden; Wim Van Criekinge; Wim Vanden Berghe; Tim Meyer

Scientific Reports 6: Article number: 20957; 10.1038/srep20957 published online: February112016; updated: March172016 The original version of this Article contained an error in the title of the paper, where the word “epigenetically” was incorrectly given as “eigenetically”. This has now been corrected in the PDF and HTML versions of the Article.


Scientific Reports | 2016

A genome-wide search for epigenetically regulated genes in zebra finch using MethylCap-seq and RNA-seq (vol 6, 20957, 2016)

Sandra Steyaert; Jolien Diddens; Jeroen Galle; Ellen De Meester; Sarah De Keulenaer; Antje Bakker; Nina Sohnius-Wilhelmi; Carolina Frankl-Vilches; Annemie Van der Linden; Wim Van Criekinge; Wim Vanden Berghe; Tim Meyer

Scientific Reports 6: Article number: 20957; 10.1038/srep20957 published online: February112016; updated: March172016 The original version of this Article contained an error in the title of the paper, where the word “epigenetically” was incorrectly given as “eigenetically”. This has now been corrected in the PDF and HTML versions of the Article.

Collaboration


Dive into the Ellen De Meester's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge